{"id":"HHS-OASH-2026-0397-2736","name":"","organization":"Rocky Mountains for Safe Technology, Susan Foster, CEO","posted":"2026-10-14T04:00Z","received":"2026-10-11T04:00Z","body":"See comment attached. \n\n*See attached additional Electromagnetic Field Studies demonstrating harmful effects published since 2019.  \n\nSusan Foster, CEO\nRocky Mountains for Safe Technology\nEmail: susan.foster04@gmail.com","source_hash":"109c0d9dd4d3f9edf9ed78b667581e395afc245b4585e2564fd3b45c1d78b1e1","filing_type":"","proceedings":"","captured_at":"","source_name":"","number":"2736","withheld":false,"attachment_inventory":true,"capture_reviewed":false,"source":"https://www.regulations.gov/comment/HHS-OASH-2026-0397-2736","slug":"research-evidence-comment-2736","tags":[],"attachments":["https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_4.pdf","https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_1.pdf","https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_3.pdf","https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_2.pdf"],"attachment_names":{"https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_4.pdf":"Tumour specific amplitude modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via tar","https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_1.pdf":"RMST HHS Comments 2019 Studies 10-2026","https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_3.pdf":"Treatment with 3 Aminobenzamide Negates the Radiofrequency Induced Adaptive Response in Two Cell Models","https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_2.pdf":"Treatment of glioblastoma with tumor specific amplitude modulated radiofrequency electromagnetic fields"},"classification":null,"supplied_classification":null,"attachment_metadata":{"https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_4.pdf":{"title":"Tumour specific amplitude modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via tar","mime":"application/pdf","source":"https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_4.pdf","upstream_key":"ca52d07c4784d65d8c5e7eff0674afa8996dd8e4fb1c8f4a1407486627c65ace","key":"ca52d07c4784d65d8c5e7eff0674afa8996dd8e4fb1c8f4a1407486627c65ace"},"https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_1.pdf":{"title":"RMST HHS Comments 2019 Studies 10-2026","mime":"application/pdf","source":"https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_1.pdf","upstream_key":"4b30297cb5d96ac9ba9d6ed96fa61e7d49bbbf7b44c7e99efeffedd8b7d0ace0","key":"4b30297cb5d96ac9ba9d6ed96fa61e7d49bbbf7b44c7e99efeffedd8b7d0ace0"},"https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_3.pdf":{"title":"Treatment with 3 Aminobenzamide Negates the Radiofrequency Induced Adaptive Response in Two Cell Models","mime":"application/pdf","source":"https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_3.pdf","upstream_key":"039285745dd769956afb44b33cfc198431fcde9da8e5514b76ffed5f559c55c8","key":"039285745dd769956afb44b33cfc198431fcde9da8e5514b76ffed5f559c55c8"},"https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_2.pdf":{"title":"Treatment of glioblastoma with tumor specific amplitude modulated radiofrequency electromagnetic fields","mime":"application/pdf","source":"https://downloads.regulations.gov/HHS-OASH-2026-0397-2736/attachment_2.pdf","upstream_key":"83df1cb1c0df53ce80708189b1ac80c6c5bd82677e3774bf666a110f80f56ec4","key":"83df1cb1c0df53ce80708189b1ac80c6c5bd82677e3774bf666a110f80f56ec4"}},"mirror_fingerprint":"7212777250c060b0e8ceb3921ac8df7ab2b5e95668c83f939e4e29b0caf6ec4e","seo_modified":"2026-10-29T15:28:52Z","forum_topics":["awaiting-review"],"primary_topic":"awaiting-review","forum_title":"See comment attached. *See attached additional Electromagnetic Field Studies demonstrating harmful effect…"}